Syncom Formulation (India) Ltd.

BSE: 524470

Expensive Performer

Download real time

16.45 -0.54 (-3.18%)

41.12% Fall from 52W High

3.9M NSE+BSE Volume

BSE 28 Mar, 2025 3:31 PM (IST)

1,546.3

Market Cap

Above industry Median

1.2

Beta 1Year

Very High Volatility

Syncom Formulation (India) Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Syncom Formulation (India) Ltd. on BSE

Load latest

Syncom Formulation (India) Ltd.

25 Sep 2024

16.45

-3.18%

SAST

SYNCOM FORMULATIONS (INDIA) LTD.-$ - 524470 - Closure of Trading Window

BSE India

Closure of Trading window for the quarter ended 30.09.2024 as per Reg 9 of SEBI(PIT) Reg, 2015

Syncom Formulation (India) Ltd.

13 Sep 2024

16.45

-3.18%

Corp. Note

SYNCOM FORMULATIONS (INDIA) LTD.-$ - 524470 - Compliances-Reg. 39 (3) - Details of Loss of Certificate …

BSE India

Intimation regarding issue of Letter of confirmation under regulation 39(3)

Syncom Formulation (India) Ltd.

07 Sep 2024

16.45

-3.18%

Company Update

SYNCOM FORMULATIONS (INDIA) LTD.-$ - 524470 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

NEWSPAPER PUBLICATION OF AGM NOTICE TO BE HELD ON 30TH SEPTEMBER, 2024 AT 2:00 P.M

Syncom Formulation (India) Ltd.

07 Sep 2024

16.45

-3.18%

Corp. Note

SYNCOM FORMULATIONS (INDIA) LTD.-$ - 524470 - Business Responsibility and Sustainability Reporting (BRSR)

BSE India

Business Responsibility and sustainability Reporting 2023-24

Syncom Formulation (India) Ltd.

07 Sep 2024

16.45

-3.18%

Corp. Note

SYNCOM FORMULATIONS (INDIA) LTD.-$ - 524470 - Reg. 34 (1) Annual Report.

BSE India

Submission of Annual Report for the year 2023-24

Syncom Formulation (India) Ltd.

05 Sep 2024

16.45

-3.18%

Company Update

SYNCOM FORMULATIONS (INDIA) LTD.-$ - 524470 - Announcement Under Reg 30 Of SEBI LODR

BSE India

We are pleased to inform you that the company has significantly expanded its portfolio of nutritional products

Syncom Formulation (India) Ltd.

05 Sep 2024

16.45

-3.18%

AGM

SYNCOM FORMULATIONS (INDIA) LTD.-$ - 524470 - Notice Of 36Th Annual General Meeting To Be Held …

BSE India

Notice of 36th Annual General Meeting of the Company to be held on Monday , the 30th day of September, 2024 at 2:00 pm through VC/OAVM

Syncom Formulation (India) Ltd.

30 Aug 2024, 03:03PM

16.45

-3.18%

Company Update

SYNCOM FORMULATIONS (INDIA) LTD.-$ - 524470 - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015 …

BSE India

Pursuant to Reg 30 of SEBI(LODR), 2015 We are pleased to inform you that the company has taken a strategic decision regarding our retail business segment.

Syncom Formulation (India) Ltd.

30 Aug 2024, 02:50PM

16.45

-3.18%

Corp. Note

SYNCOM FORMULATIONS (INDIA) LTD.-$ - 524470 - Compliances-Reg. 39 (3) - Details of Loss of Certificate …

BSE India

Intimation regarding request for issuance of Confirmation due to name deletion of shareholder due to death of the Joint holder under Regulation 39(3) of SEBI(LODR), 2015

Syncom Formulation (India) Ltd.

27 Aug 2024

16.45

-3.18%

Company Update

SYNCOM FORMULATIONS (INDIA) LTD.-$ - 524470 - Clarification sought from Syncom Formulations India Ltd

BSE India

The Exchange has sought clarification from Syncom Formulations India Ltd on August 27, 2024 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited.

No results found

Is Syncom Formulation (India) Ltd. worth buying?

864 Votes:

Buy 84.03%

Sell 8.22%

Hold 7.75%